July 6, 2017 | Israeli medical device company, Theranica Bio-electronics, has completed a $6 million Series A funding round led by Lightspeed Venture Partners. The funding will support the regulatory process and mass manufacturing of their wireless and electronic technologies to treat migraines. CEO Alon Ironi founded the company in 2016 with hopes of combining neuromodulation therapy with modern wireless technology.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments